Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
CRISPR-Cas9 is widely used to edit the genome by studying genes of interest and modifying disease-associated genes. However, this process is associated with side effects including unwanted mutations ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at their genetic source.
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...
Argininosuccinate lyase deficiency (ASLD), also known as argininosuccinic aciduria, is a disease that has been enriched in the Finnish genetic heritage. In this severe metabolic disease, the body does ...
Vertex Pharmaceuticals is licensing CRISPR’s technology for its type 1 diabetes program. The deal involves an up-front payment, milestone payments -- and the potential for royalties down the road.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback